T. Nakamura, “Initial dose of tapentadol and concomitant use of duloxetine are associated with delirium occurring after initiation of tapentadol therapy in cancer patients”, J of Opioid Management, vol. 20, no. 6, pp. 495–502, Dec. 2024.